Post by
retiredcf on Aug 12, 2022 10:51am
Good to See
Growth Model Portfolio
Increase Anaergia (ANRG) by 0.5%
Trade Rationale - The valuation looks much more digestible at 22x expected earnings and 3x forward sales. While the stock has declined significantly since we initiated a position, not much has changed in terms of the fundamentals and story so we believe most of the drop is market-related. Momentum is picking up and we are comfortable averaging down here. (5iResearch)